Rare case of infiltrative cardiomyopathy secondary to scleromyxoedema

Intern Med J. 2020 Jan;50(1):127-128. doi: 10.1111/imj.14695.

Authors

Chinmay Khandkar¹, Kaivan Vaidya¹, Ross Penglase¹, Ken Cai¹, Joo-Shik Shin¹, Imre Hunyor^{1

2}, Anthony Keech^{1

2

3}, Neil McGill^{1

2}

Affiliations

¹ Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
² University of Sydney, Sydney, New South Wales, Australia.
³ National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, New South Wales, Australia.

PMID: 31943623
DOI: 10.1111/imj.14695

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Cardiomyopathies / diagnosis*
Cardiomyopathies / diagnostic imaging
Cardiomyopathies / drug therapy
Female
Humans
Immunoglobulins, Intravenous / therapeutic use
Magnetic Resonance Imaging
Prednisolone / therapeutic use
Rare Diseases / pathology
Scleromyxedema / diagnosis*
Scleromyxedema / drug therapy
Scleromyxedema / pathology
Thalidomide / therapeutic use

Substances

Immunoglobulins, Intravenous
Thalidomide
Prednisolone